MIRA
INFORM REPORT
|
Report Date : |
30.08.2011 |
IDENTIFICATION DETAILS
|
Name : |
HERA PHARM CO., LTD. |
|
|
|
|
Registered Office : |
3FL., Gyohak Bldg. 1100-4, Hwagokbon-dong, Gangseo-gu, Seoul, Korea
157-010 |
|
|
|
|
Country : |
South Korea |
|
|
|
|
Date of Incorporation : |
11.06.2008 |
|
|
|
|
Legal Form : |
Co., Ltd by shares |
|
|
|
|
Line of Business : |
Wholesale of Pharmaceuticals |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2011
|
Country Name |
Previous Rating (31.12.2010) |
Current Rating (31.03.2011) |
|
South Korea |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Basic Information
|
Company
Name |
HERA PHARM CO., LTD. (Korean Company Name : “(주)헤라팜”) |
|
Registered Address |
1100-4, Hwagokbon-dong, Gangseo-gu, Seoul,
Korea |
|
Building |
3FL., Gyohak Bldg. |
|
Zip Code |
157-010 |
|
Tel |
+82-2-741-7592 |
|
Fax |
+82-2-741-7593 |
|
E-mail |
ckr@herapharm.co.kr;heramoll@hanmail.net |
|
Website |
|
|
Trading Address |
3FL., Gyohak Bldg., 1100-4,
Hwagokbon-dong, Gangseo-gu, Seoul, Korea |
|
Tel |
+82-2-741-7592 |
|
Fax |
+82-2-741-7593 |
|
Type |
Export/Import |
|
Industry |
Wholesale of Pharmaceuticals |
|
Main Business |
Pharmaceutical Products, Medical Devices, Information Providing for
Hospital Operational Information, Software Development |
|
Sub
Business |
Drugs & Pharmaceutical Products |
|
Established (mm/dd/yyyy) |
06/11/2008 |
The Subject Company
occupies the premises of registered HQ address by leasing base.
Detailed Products
|
Activity |
Detailed Products (UNSPSC) |
|
Sell |
Drugs and Pharmaceutical Products(51000000) |
CEO’s
|
Name |
Jeong Dae-Youn(Mobile : +82-19-220-5089) |
|
Address |
Suite 107-1805, 10, Jeonnong-dong,
Dongdaemun-gu, Seoul, Korea |
|
Date of Birth |
11/18/1968 |
|
Title |
President & CEO |
|
Sex |
Male |
|
Nationality |
Korean |
Profiles
|
Capital (KRW) |
210,000,000 |
|
Employees |
7 |
|
Formation |
Co., Ltd by shares |
|
Bank Details |
N/A |
|
Corporate Registered No. |
110111-3912957 |
|
Business Registered No. |
109-86-13*** (The full numbers are kept by
the National Tax Service confidentially.) |
|
Permit & Licenses |
N/A |
|
Shareholder Position |
N/A |
|
Company History |
06/11/2008 Incorporated as the present name 07/13/2010 Moved to the present HQ address
from 3rd
Fl., Daehan Bldg., 71-4, Hwagokbon-dong, Gangseo-gu, Seoul, Korea |
|
|
|
Management
|
Job Description |
Title |
Name |
Sex |
Nationality |
Inauguration Date |
|
President & CEO |
Mr. |
Jeong Dae-Youn |
Male |
Korean |
06/11/2008 |
|
Director |
Mr. |
Lim Hyung-Mook |
Male |
Korean |
06/11/2008 |
|
Auditor |
Mr. |
Jang Jin-Seok |
Male |
Korean |
06/11/2008 |
Financials
|
Year / Unit : KRW |
Sales |
Assets |
Net Income |
|
|
|
|
|
|
2009 |
|
|
|
|
2008 |
288,000,000 |
|
|
The latest &
full financials are not available, and the Subject Company does not have any
obligations to release its financials to the public.
Financial Description
|
Authorized Capital(KRW) |
840,000,000 |
|
Paid-Up Capital(KRW) |
210,000,000 |
|
Total Issues Shares |
42,000 |
Products, Technologies, Services Description
|
Main Products & Services |
Pharmaceutical Products, Medical Devices, Information Providing for
Hospital Operational Information, Software Development |
Trade Partners & Competitors
|
Suppliers |
LIGHT MEDICAL(USA) |
|
Competitors |
GEO-YOUNG CORPORATION 421-1, YEONHUI-DONG, SEODAEMUN-GU, SEOUL,
KOREA TEL:+82-2-3662-8222 FAX:+82-2-3141-6492 BONA MEDICAL SUPPLY CO., LTD. 787, JUNG-RI, DONGTAN-MYEON, HWASEONG-SI,
GYEONGGI-DO, KOREA TEL:+82-31-377-8091 FAX:+82-31-377-8095 BOKSAN PHARM. CO., LTD. 825-13, BEOMIL 2-DONG, DONG-GU, BUSAN,
KOREA TEL:+82-51-667-1511 FAX:+82-51-645-2365 |
Sales by Region
(Activity &
Markets)
The Subject imports
from USA.
Court Action
Not Available.
News Clipping
---
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.45.87 |
|
|
1 |
Rs.75.14 |
|
Euro |
1 |
Rs.66.68 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.